The lung immune response to nontypeable haemophilus influenzae (lung immunity to nthi)

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  King, Paul T ^a,b   Sharma, Roleen ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOMODULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROLIDE; MYELOPEROXIDASE;

ADAPTIVE IMMUNITY; BACTERIAL IMMUNITY; BRONCHIECTASIS; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY MOTILITY; CILIATED EPITHELIUM; COMPLEMENT SYSTEM; CYSTIC FIBROSIS; DISEASE EXACERBATION; EXTRACELLULAR TRAP; HAEMOPHILUS INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; INTERSTITIAL LUNG DISEASE; INTRACELLULAR SIGNALING; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LYMPHOCYTE PROLIFERATION; NEUTROPHIL; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PNEUMONIA; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOKING; VIRUS INFECTION; ADVERSE EFFECTS; ANIMAL; CLASSIFICATION; COMPLICATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; IMMUNITY; IMMUNOLOGY; INTRACELLULAR SPACE; LUNG; METABOLISM; MICROBIOLOGY; MIXED INFECTION; PHYSIOLOGY; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; COINFECTION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNITY; IMMUNITY, INNATE; INTRACELLULAR SPACE; LUNG; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; SMOKING; VIRUS DISEASES;

EID: 84934927572     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/706376     Document Type: Review

References (151)

1. T. F. Murphy, "Haemophilus infections, " in Harrisons Principles of InternalMedicine, F. Braunwald, D. L. Kaspar, S. L. Hauser, D. L. Longo, and L. Jameson, Eds., pp. 824-829, McGrawHill, New York, NY, USA, 2005.
2. J. van Eldere, M. P. Slack, S. Ladhani, and A. W. Cripps, "Non-typeable Haemophilus influenzae, an under-recognised pathogen, " The Lancet Infectious Diseases, vol. 14, no. 12, pp. 1281-1292, 2014.
3. E. R. Moxon, R. A. Deich, and C. Connelly, "Cloningof chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence, " Journal of Clinical Investigation, vol. 73, no. 2, pp. 298-306, 1984.
4. A. Zwahlen, J. S. Kroll, L. G. Rubin, and E. R. Moxon, "The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap, " Microbial Pathogenesis, vol. 7, no. 3, pp. 225-235, 1989.
5. J.W. St. Geme III, A. Takala, E. Esko, and S. Falkow, "Evidence for capsule gene sequences among pharyngeal isolates of nontypeable Haemophilus influenzae, " The Journal of Infectious Diseases, vol. 169, no. 2, pp. 337-342, 1994.
6. A. J. Howard, K. T. Dunkin, and G. W. Millar, "Nasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children, " Epidemiology and Infection, vol. 100, no. 2, pp. 193-203, 1988.
7. T. F. Murphy, S. Sethi, K. L. Klingman, A. B. Brueggemann, and G. V. Doern, "Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy, " Journal of Infectious Diseases, vol. 180, no. 2, pp. 404-409, 1999.
8. S. S. Long, F. M. Henretig, M. J. Teter, and K. L. McGowan, "Nasopharyngeal flora and acute otitis media, " Infection and Immunity, vol. 41, no. 3, pp. 987-991, 1983.
9. P. T. King, S. R. Holdsworth, N. J. Freezer, E. Villanueva, and P.W. Holmes, "Microbiologic follow-up study in adult bronchiectasis, " Respiratory Medicine, vol. 101, no. 8, pp. 1633-1638, 2007.
10. M. E. Fitzpatrick, S. Sethi, C. L. Daley, P. Ray, J. M. Beck, and M. R. Gingo, "Infections in 'noninfectious' lung diseases, " Annals of the American Thoracic Society, vol. 11, Supplement 4, pp. S221-S226, 2014.
11. M. Hilty, C. Burke, H. Pedro et al., "Disordered microbial communities in asthmatic airways, " PLoS ONE, vol. 5, no. 1, Article ID e8578, 2010.
12. J.R. Erb-Downward, D. L. Thompson, M. K. Han et al., "Analysis of the lung microbiome in the 'healthy' smoker and in COPD, " PLoS ONE, vol. 6, no. 2, Article ID e16384, 2011.
13. C. F. Clementi and T. F. Murphy, "Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract, " Frontiers in Cellular and Infection Microbiology, vol. 1, article 1, 2011.
14. J. Forsgren, A. Samuelson, A. Ahlin, J. Jonasson, B. Rynnel-Dagoo, and A. Lindberg, "Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay, " Infection and Immunity, vol. 62, no. 2, pp. 673-679, 1994.
15. I. L. Ahrén, H. Janson, A. Forsgren, and K. Riesbeck, "Protein D expression promotes the adherence and internalization of nontypeable Haemophilus influenzae into human monocytic cells, " Microbial Pathogenesis, vol. 31, no. 3, pp. 151-158, 2001.
16. I. S. Patel, T. A. R. Seemungal, M. Wilks, S. J. Lloyd-Owen, G. C. Donaldson, and J.A. Wedzicha, "Relationship between bacterial colonisation and the frequency, character, and severity ofCOPD exacerbations, " Thorax, vol. 57, no. 9, pp. 759-764, 2002.
17. L. V. M. Möller, W. Timens, W. van der Bij et al., "Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease, " The American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, pp. 950-956, 1998.
18. D. Drömann, J. Rupp, K. Rohmann et al., "The TGF-beta-Pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae, " Respiratory Research, vol. 11, article 67, 2010.
19. J. C. Hogg, "A brief review of chronic obstructive pulmonary disease, " Canadian Respiratory Journal, vol. 19, no. 6, pp. 381-384, 2012.
20. C. Fletcher and R. Peto, "The natural history of chronic airflow obstruction, " British Medical Journal, vol. 1, no. 6077, pp. 1645-1648, 1977.
21. T. F. Murphy and M. A. Apicella, "Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection, " Reviews of Infectious Diseases, vol. 9, no. 1, pp. 1-15, 1987.
22. S. Sethi and T. F. Murphy, "Chronic obstructive pulmonary disease, "The New England Journal of Medicine, vol. 343, no. 26, pp. 1969-1970, 2000.
23. V. Bandi, M. A. Apicella, E. Mason et al., "Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis, " The American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 11, pp. 2114-2119, 2001.
24. V. Bandi, M. Jakubowycz, C. Kinyon et al., "Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae, " FEMS Immunology and Medical Microbiology, vol. 37, no. 1, pp. 69-75, 2003.
25. A. Rosell, E. Monsó, N. Soler et al., "Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease, " Archives of Internal Medicine, vol. 165, no. 8, pp. 891-897, 2005.
26. K. H. Groenewegen and E. F. M. Wouters, "Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study, " Respiratory Medicine, vol. 97, no. 7, pp. 770-777, 2003.
27. A. T. Hill, E. J. Campbell, S. L. Hill, D. L. Bayley, and R. A. Stockley, "Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis, " American Journal of Medicine, vol. 109, no. 4, pp. 288-295, 2000.
28. H. Desai, K. Eschberger, C. Wrona et al., "Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease, " Annals of the American Thoracic Society, vol. 11, no. 3, pp. 303-309, 2014.
29. P. King, S. Holdsworth, N. Freezer, and P. Holmes, "Bronchiectasis, " Internal Medicine Journal, vol. 36, no. 11, pp. 729-737, 2006.
30. P. L. Molyneaux, M. J. Cox, S. A. Willis-Owen et al., "The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis, "The American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 8, pp. 906-913, 2014.
31. W. Y. Wang, J. Hyang Lim, and J.-D. Li, "Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections, " Cellular and Molecular Immunology, vol. 9, no. 2, pp. 131-135, 2012.
32. R. Singh, A. J. Mackay, A. R. Patel et al., "Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease, " Respiratory Research, vol. 15, no. 1, p. 114, 2014.
33. S. J. Moghaddam, C. G. Clement, M. M. De La Garza et al., "Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype, " American Journal of Respiratory Cell and Molecular Biology, vol. 38, no. 6, pp. 629-638, 2008.
34. T. Watanabe, H. Jono, J. Han, D. J. Lim, and J.-D. Li, "Synergistic activation of NF-κB by nontypeable Haemophilus influenzae and tumor necrosis factor α, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3563-3568, 2004.
35. S.-K. Moon, H.-Y. Lee, H. Pan et al., "Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzaeinduced up-regulation of human beta-defensin 2 in middle ear epithelial cells, " BMC Infectious Diseases, vol. 6, article 12, 2006.
36. H. Ishinaga, H. Jono, J. H. Lim et al., "TGF-β induces p65 acetylation to enhance bacteria-induced NF-κB activation, " The EMBO Journal, vol. 26, no. 4, pp. 1150-1162, 2007.
37. S. M. Wahl, "Transforming growth factor β: the good, the bad, and the ugly, " Journal of Experimental Medicine, vol. 180, no. 5, pp. 1587-1590, 1994.
38. M.-L. N. Huynh, V. A. Fadok, and P. M. Henson, "Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation, " Journal of Clinical Investigation, vol. 109, no. 1, pp. 41-50, 2002.
39. X. Xu, R. R. Steere, C. A. Fedorchuk et al., "Activation of epidermal growth factor receptor is required forNTHi-induced NF-κB-dependent inflammation, " PLoS ONE, vol. 6, no. 11, Article ID e28216, 2011.
40. J. R. D. Loria, K. Rohmann, D. Droemann et al., "Nontypeable haemophilus influenzae infection upregulates the NLRP3 inflammasome and leads to caspase-1-dependent secretion of interleukin-1β-a possible pathway of exacerbations in COPD, " PLoS ONE, vol. 8, no. 6, Article ID e66818, 2013.
41. K. A. Heyl, T. E. Klassert, A. Heinrich et al., "Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae, " MBio, vol. 5, no. 5, Article ID e01492-14, 2014.
42. S.-M. Kweon, B. Wang, D. Rixter et al., "Synergistic activation of NF-κB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKβ-IκBα, and p38 MAPK, " Biochemical and Biophysical Research Communications, vol. 351, no. 2, pp. 368-375, 2006.
43. A. J. Ratner, E. S. Lysenko, M. N. Paul, and J. N. Weiser, "Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3429-3434, 2005.
44. J. H. Lim, U. Ha, A. Sakai et al., "Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2, " BMC Immunology, vol. 9, article 40, 2008.
45. J. C. Deng, G. Cheng, M. W. Newstead et al., "Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M, " Journal of Clinical Investigation, vol. 116, no. 9, pp. 2532-2542, 2006.
46. J. H. Lim, H. Jono, T. Koga et al., "Tumor suppressor CYLD acts as a negative regulator for non-typeableHaemophilus influenzainduced inflammation in the middle ear and lung of mice, " PLoS ONE, vol. 2, no. 10, Article IDe1032, 2007.
47. A. Kovalenko, C. Chable-Bessia, G. Cantarella, A. Isräl, D. Wallach, and G. Courtois, "The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination, " Nature, vol. 424, no. 6950, pp. 801-805, 2003.
48. I. E. Wartz, K. M. O'Rourke, H. Zhou et al., "De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling, " Nature, vol. 430, no. 7000, pp. 694-699, 2004.
49. P. J. Barnes, "New anti-inflammatory targets for chronic obstructive pulmonary disease, " Nature Reviews Drug Discovery, vol. 12, no. 7, pp. 543-559, 2013.
50. F. Santamaria, S. Montella, H. A. W. M. Tiddens et al., "Structural and functional lung disease in primary ciliary dyskinesia, " Chest, vol. 134, no. 2, pp. 351-357, 2008.
51. F. W. Denny, "Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium, " Journal of Infectious Diseases, vol. 129, no. 2, pp. 93-100, 1974.
52. H. Janson, B. Carĺn, A. Cervin et al., "Effects on the ciliated epithelium of protein D-producing and-nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures, " Journal of Infectious Diseases, vol. 180, no. 3, pp. 737-746, 1999.
53. K. L. Bailey, T. D. LeVan, D. A. Yanov et al., "Non-typeable Haemophilus influenzae decreases cilia beating via protein kinase C epsilon, " Respiratory Research, vol. 13, article 49, 2012.
54. M. Goyal, M. Singh, P. Ray, R. Srinivasan, and A. Chakraborti, "Cellular interaction of nontypeable Haemophilus influenzae triggers cytotoxicity of infected type II alveolar cells via apoptosis, " Pathogens and Disease, vol. 73, no. 2, pp. 1-12, 2014.
55. H. Jono, T. Shuto, H. Xu et al., "Transforming growth factor-β-Smad signaling pathway cooperates with NF-κB to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription, " Journal of Biological Chemistry, vol. 277, no. 47, pp. 45547-45557, 2002.
56. O. A. Khair, R. J. Davies, and J. L. Devalia, "Bacterial-induced release of inflammatory mediators by bronchial epithelial cells, " European Respiratory Journal, vol. 9, no. 9, pp. 1913-1922, 1996.
57. J. M. Gould and J. N. Weiser, "Expression of C-reactive protein in the human respiratory tract, " Infection and Immunity, vol. 69, no. 3, pp. 1747-1754, 2001.
58. T. Hallström and K. Riesbeck, "Haemophilus influenzae and the complement system, " Trends in Microbiology, vol. 18, no. 6, pp. 258-265, 2010.
59. M.M. Marc, P. Korosec, M. Kosnik et al., "Complement factors C3a, C4a, and C5a in chronic obstructive pulmonary disease and asthma, " The American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 2, pp. 216-219, 2004.
60. C. V. Rosadini, S. Ram, and B. J. Akerleya, "Outer membrane protein p5 is required for resistance of nontypeable haemophilus influenzae to both the classical and alternative complement pathways, " Infection and Immunity, vol. 82, no. 2, pp. 640-649, 2014.
61. S. Nakamura, M. Shchepetov, A. B. Dalia et al., "Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae, " PLoS Pathogens, vol. 7, no. 1, Article ID e1001247, 2011.
62. Y.-C. Su, F. Jalalvand, M. Mörgelin, A. M. Blom, B. Singh, and K. Riesbeck, "Haemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunity, " Molecular Microbiology, vol. 87, no. 6, pp. 1245-1266, 2013.
63. T. W. Du Clos and C. Mold, "Complement in host deficiencies and disease, " in Clinical Immunology: Principles and Practice, R. R. Rich, T. A. Fleisher, W. T. Shearer, H. W. Schroeder, A. J. Frew and, and C. M. Weyand, Eds., pp. 252-269, Elsevier, Philadelphia, Pa, USA, 2013.
64. J. D. Chalmers, B. J. McHugh, C. Doherty et al., "Mannosebinding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study, " The Lancet Respiratory Medicine, vol. 1, no. 3, pp. 224-232, 2013.
65. C. W. Wieland, S. Florquin, N. A. Maris et al., "The MyD88-dependent, but not theMyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung, " Journal of Immunology, vol. 175, no. 9, pp. 6042-6049, 2005.
66. X. Wang, C. Moser, J.-P. Louboutin et al., "Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung, "The Journal of Immunology, vol. 168, no. 2, pp. 810-815, 2002.
67. T. Shuto, H. Xu, B. Wang et al., "Activation of NF-κB by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKKα/β-IκBα andMKK3/6-p38 MAP kinase signaling pathways in epithelial cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8774-8779, 2001.
68. F. Xu, Z. Xu, R. Zhang et al., "Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B, " Respiratory Research, vol. 9, article 16, 2008.
69. C. S. Berenson, R. L. Kruzel, E. Eberhardt et al., "Impaired innate immune alveolarmacrophage response and the predilection forCOPDexacerbations, " Thorax, vol. 69, no. 9, pp. 811-818, 2014.
70. C. S. Berenson, M. A. Garlipp, L. J. Grove, J. Maloney, and S. Sethi, "Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease, " Journal of Infectious Diseases, vol. 194, no. 10, pp. 1375-1384, 2006.
71. A. E. Taylor, T. K. Finney-Hayward, J. K. Quint et al., "Defective macrophage phagocytosis of bacteria in COPD, " European Respiratory Journal, vol. 35, no. 5, pp. 1039-1047, 2010.
72. C. J. Harvey, R. K. Thimmulappa, S. Sethi et al., "Targeting Nrf2 signaling improves bacterial clearance by alveolarmacrophages in patients with COPD and in a mousemodel, " Science Translational Medicine, vol. 3, no. 78, Article ID 78ra32, 2011.
73. C. S. Berenson, R. L. Kruzel, E. Eberhardt, and S. Sethi, "Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease, " The Journal of Infectious Diseases, vol. 208, no. 12, pp. 2036-2045, 2013.
74. P. T. King, R. Sharma, K. O'Sullivan et al., "Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression, " PLoS ONE, 2015.
75. C. S. Berenson, C. T. Wrona, L. J. Grove et al., "Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease, " American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 1, pp. 31-40, 2006.
76. R. A. Juneau, B. Pang, K. W. D. Weimer, C. E. Armbruster, and W. E. Swords, "Nontypeable haemophilus influenzae initiates formation of neutrophil extracellular traps, " Infection and Immunity, vol. 79, no. 1, pp. 431-438, 2011.
77. P. T. King, J. Ngui, M.W. Farmer, P. Hutchinson, P.W. Holmes, and S. R. Holdsworth, "Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae, " Clinical and Experimental Immunology, vol. 152, no. 3, pp. 542-551, 2008.
78. G. Uzel and S. Holland, "Phagocyte deficiencies, " in Clinical Immunology: Principles and Practice, R. R. Rich, T. A. Fleisher, W. T. Shearer, H. W. Schroeder, A. J. Frew and, and C. M. Weyand, Eds., pp. 270-283, Elsevier, Philadelphia, Pa, USA, 2013.
79. K. Groeneveld, P. P. Eijk, L. Van Alphen, H. M. Jansen, and H. C. Zanen, "Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum, " American Review of Respiratory Disease, vol. 141, no. 5, pp. 1316-1321, 1990.
80. M. V. Hansen, D. M. Musher, and R. E. Baughn, "Outer membrane proteins of nontypable Haemophilus influenzae and reactivity of paired sera from infected patients with their homologous isolates, " Infection and Immunity, vol. 47, no. 3, pp. 843-846, 1985.
81. K. Yi and T. F. Murphy, "Mapping of a strain-specific bactericidal epitope to the surface-exposed loop 5 on the P2 porin protein of non-typeable Haemophilus influenzae, " Microbial Pathogenesis, vol. 17, no. 4, pp. 277-282, 1994.
82. T. F. Murphy, L. C. Bartos, A.A. Campagnari, M. B. Nelson, and M. A. Apicella, "Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae, " Infection and Immunity, vol. 54, no. 3, pp. 774-779, 1986.
83. W. H. Badr, D. Loghmanee, R. J. Karalus, T. F. Murphy, and Y. Thanavala, "Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses, " Vaccine, vol. 18, no. 1-2, pp. 29-37, 1999.
84. Y. M. T. A. van Durme, K. M. C. Verhamme, T. Stijnen, and et al, "Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the rotterdamstudy, " Chest, vol. 135, no. 2, pp. 368-377, 2009.
85. P. T. King, J. Ngui, D. Gunawardena, P. W. Holmes, M. W. Farmer, and S. R. Holdsworth, "Systemic humoral immunity to non-typeable Haemophilus influenzae, " Clinical and Experimental Immunology, vol. 153, no. 3, pp. 376-384, 2008.
86. D. C. Otczyk, R. L. Clancy, and A. W. Cripps, "Haemophilus influenzae and smoking-related obstructive airways disease, " International Journal of ChronicObstructive PulmonaryDisease, vol. 6, no. 1, pp. 345-351, 2011.
87. S. Sethi, N. Evans, B. J. B. Grant, and T. F. Murphy, "New strains of bacteria and exacerbations of chronic obstructive pulmonary disease, "TheNew England Journal ofMedicine, vol. 347, no. 7, pp. 465-471, 2002.
88. S. Sethi, C. Wrona, B. J. B. Grant, and T. F. Murphy, "Strainspecific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 4, pp. 448-453, 2004.
89. T. F. Murphy, A. L. Brauer, S. Sethi, M. Kilian, X. Cai, and A. J. Lesse, "Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae, " Journal of Infectious Diseases, vol. 195, no. 1, pp. 81-89, 2007.
90. T. F. Murphy, A. L. Brauer, A. T. Schiffmacher, and S. Sethi, "Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease, " The American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 3, pp. 266-272, 2004.
91. D. M. Musher, A. Goree, R. E. Baughn, and H. H. Birdsall, "Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae, " Infection and Immunity, vol. 45, no. 1, pp. 36-40, 1984.
92. B. Meshi, T. Z. Vitalis, D. Ionescu et al., "Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response, "American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 1, pp. 52-57, 2002.
93. G. G. Brusselle, G. F. Joos, and K. R. Bracke, "New insights into the immunology of chronic obstructive pulmonary disease, " The Lancet, vol. 378, no. 9795, pp. 1015-1026, 2011.
94. C. F. Clementi, A. P. Hakansson, and T. F. Murphy, "Internalization and trafficking of nontypeable Haemophilus influenzae in human respiratory epithelial cells and roles of IgA1 proteases for optimal invasion and persistence, " Infection and Immunity, vol. 82, no. 1, pp. 433-444, 2014.
95. D. M. Musher and R. J. Wallace Jr., "Bacteremic infections caused by nontypable Haemophilus influenzae in patients with dysgammaglobulinemia, " Journal of Clinical Microbiology, vol. 17, no. 1, pp. 143-145, 1983.
96. A. Samuelson, S. Borrelli, R. Gustafson et al., "Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations, " Scandinavian Journal of Infectious Diseases, vol. 27, no. 4, pp. 303-313, 1995.
97. J. C. H. van der Hilst, B. W. Smits, and J. W. M. van der Meer, "Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution, " Netherlands Journal of Medicine, vol. 60, no. 3, pp. 140-147, 2002.
98. K. Lindberg, R. Gustafson, A. Samuelson, and B. Rynnel-Dagoo, "Impact of IgG replacement therapy and antibiotic treatment on the colonization of non-encapsulated Haemophilus influenzae in the nasopharynx in patients with hypogammaglobulinaemia, " Scandinavian Journal of Infectious Diseases, vol. 33, no. 12, pp. 904-908, 2001.
99. Y. Abe, T. F. Murphy, S. Sethi et al., "Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease, " The American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 967-971, 2002.
100. P. T. King, P. E. Hutchinson, P. D. Johnson, P. W. Holmes, N. J. Freezer, and S. R. Holdsworth, "Adaptive immunity to nontypeable Haemophilus influenzae, " American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 4, pp. 587-592, 2003.
101. P. King, J. Ngui, F. Oppedisano, R. Robins-Browne, P. Holmes, and S. Holdsworth, "Effect of interferon gamma and CD40 ligation on intracellular monocyte survival of nontypeable Haemophilus influenzae, " APMIS, vol. 116, no. 12, pp. 1043-1049, 2008.
102. J. Knobloch, K. Schild, D. Jungck et al., "The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD, " American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 2, pp. 204-214, 2011.
103. S. G. Kalathil, A. A. Lugade, V. Pradhan et al., "T-regulatory cells and programmed death 1+ T cells contribute to effector Tcell dysfunction in patientswith chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 1, pp. 40-50, 2014.
104. S. J. Pizzutto, S. T. Yerkovich, J. W. Upham et al., "Children with chronic suppurative lung disease have a reduced capacity to synthesize interferon-gamma in vitro in response to nontypeable Haemophilus influenzae, " PLoS ONE, vol. 9, no. 8, Article ID e104236, 2014.
105. P. T. King, S. Lim, A. Pick et al., "Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease, " Journal of Allergy and Clinical Immunology, vol. 131, no. 5, pp. 1314-1321, 2013.
106. A.-T. Essilfie, J. L. Simpson, J. C. Horvat et al., "Haemophilus influenzae infection drives IL-17-mediated neutrophilic Allergic airways disease, " PLoS Pathogens, vol. 7, no. 10, Article ID e1002244, 2011.
107. A.-T. Essilfie, J. L. Simpson, M. L. Dunkley et al., "Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma, " Thorax, vol. 67, no. 7, pp. 588-599, 2012.
108. T. A. Wynn, "Fibrotic disease and the TH1/TH2 paradigm, " Nature Reviews Immunology, vol. 4, no. 8, pp. 583-594, 2004.
109. H. J. Zar, "Chronic lung disease in human immunodeficiency virus (HIV) infected children, " Pediatric Pulmonology, vol. 43, no. 1, pp. 1-10, 2008.
110. R. Masekela, R. Anderson, T. Moodley et al., "HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas, " International Journal of Tuberculosis and Lung Disease, vol. 16, no. 1, pp. 114-119, 2012.
111. M. R. Stmpfli and G. P. Anderson, "How cigarette smoke skewsimmune responses to promote infection, lung disease and cancer, " Nature Reviews Immunology, vol. 9, no. 5, pp. 377-384, 2009.
112. G. J. Gaschler, M. Skrtic, C. C. J. Zavitz et al., "Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile, " American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 8, pp. 666-675, 2009.
113. P. Mart-Lliteras, V. Regueiro, P. Morey et al "Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke, " Infection and Immunity, vol. 77, no. 10, pp. 4232-4242, 2009.
114. S. Halappanavar, J. Nikota, D. Wu, A. Williams, C. L. Yauk, and M. Stampfli, "IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smokeinduced inflammation, " Journal of Immunology, vol. 190, no. 7, pp. 3679-3686, 2013.
115. H. J. Metcalfe, S. Lea, D. Hughes, R. Khalaf, K. Abbott-Banner, and D. Singh, "Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages, " Clinical and Experimental Immunology, vol. 176, no. 3, pp. 461-472, 2014.
116. A. A. Lugade, P. N. Bogner, T. H. Thatcher, P. J. Sime, R. P. Phipps, and Y. Thanavala, "Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection, " Journal of Immunology, vol. 192, no. 11, pp. 5226-5235, 2014.
117. J. A. Wedzicha, "Role of viruses in exacerbations of chronic obstructive pulmonary disease, " Proceedings of the American Thoracic Society, vol. 1, no. 2, pp. 115-120, 2004.
118. T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, M. Wilks, G. C. Donaldson, and J. A. Wedzicha, "Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD, " Chest, vol. 129, no. 2, pp. 317-324, 2006.
119. A. Papi, C. M. Bellettato, F. Braccioni et al., "Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations, " American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 10, pp. 1114-1121, 2006.
120. P. Mallia, J. Footitt, R. Sotero et al., "Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical CareMedicine, vol. 186, no. 11, pp. 1117-1124, 2012.
121. P. L. Molyneaux, P. Mallia, M. J. Cox et al., "Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease, " American Journal of Respiratory and Critical CareMedicine, vol. 188, no. 10, pp. 1224-1231, 2013.
122. U. Sajjan, Q. Wang, Y. Zhao, D. C. Gruenert, and M. B. Hershenson, "Rhinovirus disrupts the barrier function of polarized airway epithelial cells, " American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 12, pp. 1271-1281, 2008.
123. B. L. Unger, A. N. Faris, S. Ganesan, A. T. Comstock, M. B. Hershenson, and U. S. Sajjan, "Rhinovirus attenuates nontypeable Hemophilus influenzae-stimulated IL-8 responses via TLR2-dependent degradation of IRAK-1, " PLoS Pathogens, vol. 8, no. 10, Article ID e1002969, 2012.
124. J. F. Brundage, "Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness, " The Lancet Infectious Diseases, vol. 6, no. 5, pp. 303-312, 2006.
125. D. M. Morens, J. K. Taubenberger, and A. S. Fauci, "Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, " The Journal of Infectious Diseases, vol. 198, no. 7, pp. 962-970, 2008.
126. R. K. Albert, J. Connett, W. C. Bailey et al., "Azithromycin for prevention of exacerbations of COPD, " The New England Journal of Medicine, vol. 365, no. 8, pp. 689-698, 2011.
127. C. Wong, L. Jayaram, N. Karalus et al., "Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial, " The Lancet, vol. 380, no. 9842, pp. 660-667, 2012.
128. D. J. Serisier, M. L. Martin, M. A. McGuckin et al., "Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial, " Journal of theAmerican Medical Association, vol. 309, no. 12, pp. 1260-1267, 2013.
129. J. I. Gallin, H. L. Malech, R. S. Weening et al., "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, "The New England Journal of Medicine, vol. 324, no. 8, pp. 509-516, 1991.
130. D. B. Kuhns, W. G. Alvord, T. Heller et al., "Residual NADPH oxidase and survival in chronic granulomatous disease, " The New England Journal of Medicine, vol. 363, no. 27, pp. 2600-2610, 2010.
131. S. M. Holland, E. M. Eisenstein, D. B. Kuhns et al., "Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report, " The New England Journal ofMedicine, vol. 330, no. 19, pp. 1348-1355, 1994.
132. M. C. Morissette, P. Shen, D. Thayaparan, and M. R. Stampfli, "Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria, " European Respiratory Journal, vol. 45, no. 1, pp. 191-200, 2014.
133. A. Agrawal and T. F. Murphy, "Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era, " Journal of Clinical Microbiology, vol. 49, no. 11, pp. 3728-3732, 2011.
134. K. L. Ostberg, M. W. Russell, and T. F. Murphy, "Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae, " Mucosal Immunology, vol. 2, no. 1, pp. 63-73, 2009.
135. R.W. Johnson, G. McGillivary, P. Denoël, J. Poolman, and L.O. Bakaletz, "Abrogation of nontypeable Haemophilus influenzae Protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitismedia, " Vaccine, vol. 29, no. 6, pp. 1211-1221, 2011.
136. J. T. Poolman, L. Bakaletz, A. Cripps et al., "Developing a nontypeable Haemophilus influenzae (NTHi) vaccine, " Vaccine, vol. 19, no. 1, pp. S108-S115, 2000.
137. L. A. Novotny, J. A. Jurcisek, F. Godfroid, J. T. Poolman, P. A. Denoël, and L. O. Bakaletz, "Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae, " Vaccine, vol. 24, no. 22, pp. 4804-4811, 2006.
138. Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2013, http://www.goldcopd.org.
139. R. Prymula, P. Peeters, V. Chrobok et al., "Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitismedia caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised doubleblind efficacy study, " The Lancet, vol. 367, no. 9512, pp. 740-748, 2006.
140. D. M. Mannino and A. S. Buist, "Global burden of COPD: risk factors, prevalence, and future trends, " The Lancet, vol. 370, no. 9589, pp. 765-773, 2007.
141. A. Cavaillès, G. Brinchault-Rabin, A. Dixmier et al., "Comorbidities of COPD, " European Respiratory Review, vol. 22, no. 130, pp. 454-475, 2013.
142. S. Suissa, S. Dell'Aniello, and P. Ernst, "Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality, " Thorax, vol. 67, no. 11, pp. 957-963, 2012.
143. A. S. Gershon, L. Warner, P. Cascagnette, J. C. Victor, and T. To, "Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study, " The Lancet, vol. 378, no. 9795, pp. 991-996, 2011.
144. J. Vestbo, S. S. Hurd, A. G. Agustí et al. "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary, " American Journal of Respiratory and Critical CareMedicine, vol. 187, no. 4, pp. 347-365, 2013.
145. M. D. Carruthers, E. N. Tracy, A. C. Dickson, K. B. Ganser, R. S. Munson Jr., and L. O. Bakaletz, "Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and comoperons, " Journal of Bacteriology, vol. 194, no. 8, pp. 1927-1933, 2012.
146. R. Clancy, K. Murree-Allen, A. Cripps, S. Yeung, andM. Engel, "Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease, " The Lancet, vol. 2, no. 8469-8470, pp. 1395-1398, 1985.
147. A. R. Foxwell, A. W. Cripps, and K. B. Dear, "Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis, " The Cochrane Database of Systematic Reviews, no. 4, Article ID CD001958, 2006.
148. M. K. Tandon, M. Phillips, G. Waterer, M. Dunkley, P. Comans, and R. Clancy, "Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD, " Chest, vol. 137, no. 4, pp. 805-811, 2010.
149. A. A. Palmu, J. Jokinen, H. Nieminen et al., "Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a doubleblind, cluster randomised phase 3-4 trial, " The Lancet Infectious Diseases, vol. 14, no. 3, pp. 205-212, 2014.
150. E. Teo, H. House, K. Lockhart et al., "Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease, " The Cochrane Database of Systematic Reviews, vol. 9, Article ID CD010010, 2014.
151. P. L. Winokur, K. Chaloner, G. V. Doern, J. Ferreira, and M. A. Apicella, "Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae, " Journal of Infectious Diseases, vol. 208, no. 5, pp. 728-738, 2013.